Encochleated Amphotericin B
MB-70009
Phase 2 small_molecule terminated
Quick answer
Encochleated Amphotericin B for Cryptococcal Infections is a Phase 2 program (small_molecule) at Matinas BioPharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Matinas BioPharma Holdings
- Indication
- Cryptococcal Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated